Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol2018-01-17T17:05:35-05:00
Silencing Autoimmunity in Multiple Sclerosis, Lupus, and Rheumatoid Arthritis Silencing Autoimmunity in Multiple Sclerosis, Lupus, and Rheumatoid Arthritis2018-01-17T17:05:35-05:00
Financial Conflicts of Interest and the Food and Drug Administration’s Advisory Committees Financial Conflicts of Interest and the Food and Drug Administration’s Advisory Committees2018-01-17T17:05:18-05:00
Growth factor treatment of demyelinating disease: at last, a leap into the light Growth factor treatment of demyelinating disease: at last, a leap into the light2018-01-17T17:05:11-05:00
New directions in MS therapeutics: vehicles of hope New directions in MS therapeutics: vehicles of hope2018-01-17T17:05:11-05:00
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis2018-01-17T17:05:05-05:00
Bystander Modulation of Chemokine Receptor Expression on Peripheral Blood T Lymphocytes Mediated by Glatiramer Therapy Bystander Modulation of Chemokine Receptor Expression on Peripheral Blood T Lymphocytes Mediated by Glatiramer Therapy2018-01-17T17:04:58-05:00
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines2018-01-17T17:04:58-05:00
The reproductive effects of beta interferon therapy in pregnancy The reproductive effects of beta interferon therapy in pregnancy2018-01-17T17:04:53-05:00
